Categories: Bloodborne pathogens, Ebola, Emergency Response/Public Sector, Health care, Personal Protective Equipment
November 7th, 2014 6:45 am ET -
John Howard, MD; Margaret Kitt, MD; Maryann D’Alessandro, PhD; Lisa Delaney, MS, CIH; Chad Dowell MS, CIH
On November 3, the Institute of Medicine and the National Research Council of the National Academies convened a workshop of distinguished representatives from the public and private sectors. The participants were asked to suggest priorities for research that will “provide public health officials, healthcare providers, and the general public with the most up-to-date information about transmission, health risks, and measures that should be taken to prevent spread of [Ebola virus disease] in the U.S.” NIOSH was pleased to contribute to this dialogue, specifically by addressing issues critical for protecting heath care workers from work-related infection.
Researchers and practitioners have decades of experience related to the use of sampling, analysis, personal protective equipment (PPE) and other traditional measures for assessing exposures and minimizing the risks of occupational illness and injury in the industrial setting. That knowledge underpins standard industrial hygiene practices in factories, mines, and construction sites. Strategic research is vital for building a comparably robust base of evidence for reducing occupational risks from infectious diseases in the complex health care setting. By stimulating the knowledge needed to better meet the challenges of Ebola today, we also lay a stronger foundation for anticipating tomorrow’s potential threats from other novel infectious diseases in our 21st Century world of international commerce and rapid air travel.
6 Comments -
Categories: Observances, Personal Protective Equipment, Respiratory Health
September 5th, 2014 7:42 am ET -
Jaclyn Krah, MA
N95 Day is finally here again. We hope that you have been looking forward to it as much as we have! N95 Day has become an annual observance, now in its third year. This year we are focusing on the specific theme of “Respiratory Preparedness: Where Technology Meets Good Practices.” Confidence and familiarity with proper respirator practices is important for employers, respiratory protection program managers, and safety managers in all industries who rely on N95 respiratory protection to help keep workers safe. The education to build this familiarity must happen before the time comes where a respirator is needed.
3 Comments -
Categories: Health care, Personal Protective Equipment
June 26th, 2014 8:07 am ET -
Lindsay Stradtman, MPH; Jaclyn Krah, MA; Debra Novak, PhD, RN
Every day healthcare workers (HCWs) make decisions about the best way to protect themselves. What would you do if you entered the room of a new patient and noticed symptoms such as fever and a mucus-producing cough? As a HCW, you must then ask yourself, “What type of disease does the patient have? What sort of precautions should I take to protect myself because the patient may have an infectious disease?” While it is your employer’s responsibility to provide policies, programs, training, and guidance on respirator use, it is the health care workers who implement these procedures. Do you know when to use respiratory protection? If so, do you understand what type of protection to choose and how to use it properly?
3 Comments -
Categories: Agriculture, Forestry, and Fishing, Construction, Emergency Response/Public Sector, Oil and Gas, Outdoor Work, Personal Protective Equipment, Respiratory Health
April 23rd, 2014 8:02 am ET -
Marie A. de Perio, MD; Gregory A. Burr, CIH
A prison located in an arid, hyperendemic area of the Central Valley of California. There is little natural vegetation on the grounds and in the surrounding areas. Photograph by NIOSH.
Coccidioidomycosis, also known as Valley Fever, is a disease caused by the fungus Coccidioides. The fungus grows in the soil in very dry areas. Coccidioidomycosis is endemic (native and common) in the southwestern United States, the Central Valley of California, Mexico, and parts of Central and South America [CDC 2013a]. About 150,000 new infections have been estimated to occur each year in the United States [Galgiani et al. 2005] but only about 22,000 cases were reported in 2011 in the United States. This suggests that the disease is greatly underreported [CDC 2013b]. The apparent incidence of reported coccidioidomycosis increased from 1998 to 2011, from 5.3 cases per 100,000 population in the endemic area (Arizona, California, Nevada, New Mexico, and Utah) in 1998 to 42.6 cases per 100,000 in 2011, although concern has been expressed that some of this increase might be related to changes in surveillance definitions, laboratory practices, and increased awareness leading to increased testing for the disease [CDC 2013b].
8 Comments -